SUSMED,Inc.
Tokyo Stock Exchange 4263.T
SUSMED,Inc. Operating Income for the year ending June 30, 2024: USD -2.27 M
SUSMED,Inc. Operating Income is USD -2.27 M for the year ending June 30, 2024, a -578.86% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
-
SUSMED,Inc. Operating Income for the year ending June 30, 2023 was USD -334.73 K, a 80.16% change year over year.
-
SUSMED,Inc. Operating Income for the year ending June 30, 2022 was USD -1.69 M, a 43.77% change year over year.
-
SUSMED,Inc. Operating Income for the year ending June 30, 2021 was USD -3.00 M, a -101.60% change year over year.
-
SUSMED,Inc. Operating Income for the year ending June 30, 2020 was USD -1.49 M.
Key data
| Date | Operating Income | EBIT | EBITDA | Net Income |
|---|
Market news
Loading...
Tokyo Stock Exchange: 4263.T
| CEO | Mr. Taro Ueno |
| IPO Date | Dec. 24, 2021 |
| Location | Japan |
| Headquarters | MFPR Nihonbashi honcho Bldg |
| Employees | 39 |
| Sector | Health Care |
| Industries | |
Description
SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email